[
    [
        {
            "time": "",
            "original_text": "细数2018国内医药圈“蛇吞象”并购案TOP10",
            "features": {
                "keywords": [
                    "2018",
                    "医药圈",
                    "蛇吞象",
                    "并购案",
                    "TOP10"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "细数2018国内医药圈“蛇吞象”并购案TOP10",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "10余家药企忙与“芬太尼”撇清关系 14只麻醉概念股意外飘红",
            "features": {
                "keywords": [
                    "药企",
                    "芬太尼",
                    "麻醉概念股",
                    "飘红"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "10余家药企忙与“芬太尼”撇清关系 14只麻醉概念股意外飘红",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【医药-马帅】塞力斯深度：SPD业务先发优势显著，预计未来三年净利润复合增速约为50%",
            "features": {
                "keywords": [
                    "医药",
                    "塞力斯",
                    "SPD业务",
                    "先发优势",
                    "净利润",
                    "复合增速",
                    "50%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药-马帅】塞力斯深度：SPD业务先发优势显著，预计未来三年净利润复合增速约为50%",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]